Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BAY 3547926 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on BAY 3547926, a putative radiotherapy (Jan 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BAY 3547926 | BAY3547926|BAY-3547926 | Limited information is currently available on BAY 3547926, a putative radiotherapy (Jan 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06764316 | Phase I | BAY 3547926 | A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer | Recruiting | GBR | FIN | ESP | CAN | BEL | 0 |